New Delhi: The Department of Pharmaceuticals (DoP) has rejected Cipla Ltd's review application challenging the ceiling price fixed for Acivir 800 mg Tablet DT 5's by the National Pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback